Peptide price index — Q3 2026
A market snapshot of per-milligram peptide pricing across 58 peptides with verified pricing data, computed from scraped research-vendor prices, normalized to milligrams, and winsorized to remove outliers. Figures describe the research-chemical market and are not a clinical pricing reference.
58
Peptides tracked
$5.39/mg
Market median
307.8×
Price dispersion
2,074
Vendor observations
Median per-mg prices span 307.8× across the index — from $0.450/mg at the low end to $138.50/mg at the high end — reflecting wide variation in synthesis complexity and vendor positioning.
Top price movers
Largest changes in median per-mg price over the tracked history window (earliest vs. latest recorded day).
| Peptide | Was | Now | Change |
|---|---|---|---|
| NAD+ | $0.147 | $0.460 | +212.9% |
| 5-Amino-1MQ | $1.28 | $3.61 | +182.1% |
| Hexarelin | $4.96 | $9.21 | +85.5% |
| Sermorelin | $5.00 | $8.40 | +67.9% |
| GHRP-6 | $7.60 | $2.98 | -60.8% |
| Oxytocin | $4.50 | $7.06 | +56.9% |
| Retatrutide | $10.90 | $4.97 | -54.4% |
| Thymosin Alpha-1 | $9.95 | $5.54 | -44.3% |
| Foxo4-DRI | $20.00 | $12.18 | -39.1% |
| Kisspeptin-10 | $6.57 | $4.00 | -39.1% |
Pricing by category
| Category | Peptides | Median $/mg | Range $/mg |
|---|---|---|---|
| Skin Joint | 3 | $3.00 | $0.700–$3.50 |
| Longevity | 14 | $3.00 | $0.450–$21.70 |
| Cognitive | 6 | $4.38 | $0.833–$10.50 |
| Sexual Health | 4 | $4.94 | $4.00–$12.47 |
| Recovery | 10 | $6.89 | $2.75–$16.77 |
| Fat Loss | 10 | $7.65 | $2.90–$12.91 |
| Performance | 11 | $9.07 | $1.10–$138.50 |
Methodology
Prices are scraped from research-vendor product listings, normalized to a per-milligram basis, and winsorized to the 5th–95th percentile to remove outliers. A peptide qualifies for this study only when it has priced listings from at least five distinct active vendors. Percentiles (p25, median, p75) are SQL aggregates — not curated or hand-ranked.
Placement in this study: 0 paid placements.
PeptideBase accepts no payment for inclusion in this study.
PeptideBase takes no affiliate commission on vendor sales.
Top movers compare the earliest and latest recorded daily median per-mg price for each peptide over the accumulated history window. Category figures are the median of per-peptide medians within each category.
Most prices reflect research-use vendors, whose products are sold for research purposes only and are not intended for human use. Clinical program pricing (telehealth, compounding pharmacy with prescription) follows a different model and is not captured here. Do not use this study as a clinical pricing reference. This is educational and informational content, not medical advice.
Cite this page
Data last updated October 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Peptide Price Index — Q3 2026 Market Study. Retrieved October 26, 2026, from https://peptidebase.io/data/peptide-price-index-q3-2026